SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vasomedical Inc.
VASO 0.170-1.0%Dec 15 3:36 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Antonios Petropoulos who wrote (443)6/22/1997 7:06:00 AM
From: Francois H. Gaston   of 1605
 
Marked increase in volume. Obviously due to the recent PPO news. That is very bullish, despite only a modest increase in share price for the say.
That Georgia deal will simply double the EECP centers in the country. Mainly in the Geogia state. That is very promising, especially if other regions start to lay down similar plans.
This suggests to me that this PPO must have a good feeling that the study is positive, and that EECP might become an atlernate treatment to severe angina. Remember that some insurances reimburse EECP on an individual case basis. Time to gamble IMHO.
The fact that the VASO news are not covered well... just remember the activity last Spring. If the study is really positive, VASO stock price will experience a substantial rise.
It is quite possible that we might be above $2 this week (hard to predict, but I think we will be because this type of news is what VASO needs: a committment from a large healtcare provider. Time will tell.
FHG
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext